SK286755B6 - Antitrombotické zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents

Antitrombotické zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie Download PDF

Info

Publication number
SK286755B6
SK286755B6 SK1922-2000A SK19222000A SK286755B6 SK 286755 B6 SK286755 B6 SK 286755B6 SK 19222000 A SK19222000 A SK 19222000A SK 286755 B6 SK286755 B6 SK 286755B6
Authority
SK
Slovakia
Prior art keywords
alkyl
compounds
antithrombotic
compound
antithrombotic compounds
Prior art date
Application number
SK1922-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK19222000A3 (sk
Inventor
Johannes Egbertus Maria Basten
Boeckel Constant Adriaan Anton Van
Rogier Christian Buijsman
Cornelia Maria Dreef-Tromp
Original Assignee
Universiteit Leiden
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universiteit Leiden, N.V. Organon filed Critical Universiteit Leiden
Publication of SK19222000A3 publication Critical patent/SK19222000A3/sk
Publication of SK286755B6 publication Critical patent/SK286755B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
SK1922-2000A 1998-06-17 1999-06-11 Antitrombotické zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie SK286755B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98202037 1998-06-17
PCT/EP1999/004100 WO1999065934A1 (en) 1998-06-17 1999-06-11 Antithrombotic compounds

Publications (2)

Publication Number Publication Date
SK19222000A3 SK19222000A3 (sk) 2001-07-10
SK286755B6 true SK286755B6 (sk) 2009-05-07

Family

ID=8233825

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1922-2000A SK286755B6 (sk) 1998-06-17 1999-06-11 Antitrombotické zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie

Country Status (31)

Country Link
US (1) US6486129B1 (ja)
EP (1) EP1087992B1 (ja)
JP (1) JP4369052B2 (ja)
KR (1) KR100790910B1 (ja)
CN (1) CN1261450C (ja)
AR (1) AR019674A1 (ja)
AT (1) ATE405580T1 (ja)
AU (1) AU756493B2 (ja)
BR (1) BR9911300A (ja)
CA (1) CA2334863C (ja)
CO (1) CO5080750A1 (ja)
CY (1) CY1108567T1 (ja)
CZ (1) CZ299382B6 (ja)
DE (1) DE69939378D1 (ja)
DK (1) DK1087992T3 (ja)
ES (1) ES2312210T3 (ja)
HK (1) HK1034266A1 (ja)
HU (1) HU229088B1 (ja)
ID (1) ID26614A (ja)
IL (2) IL139955A0 (ja)
NO (1) NO326057B1 (ja)
NZ (1) NZ508623A (ja)
PE (1) PE20000700A1 (ja)
PL (1) PL199433B1 (ja)
PT (1) PT1087992E (ja)
RU (1) RU2225869C2 (ja)
SK (1) SK286755B6 (ja)
TR (1) TR200003710T2 (ja)
TW (1) TWI221156B (ja)
WO (1) WO1999065934A1 (ja)
ZA (1) ZA200007075B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2334863C (en) * 1998-06-17 2011-02-15 Akzo Nobel Nv Antithrombotic compounds
TWI289566B (en) 1999-12-07 2007-11-11 N.V.Organon Antithrombotic compound
DE10049937A1 (de) * 2000-10-06 2002-04-11 Knoll Ag Niedermolekulare Inhibitoren von Serinproteasen mit Polyhydroxyalkyl- und Polyhydroxycycloalkylresten
BR0307266A (pt) * 2002-01-31 2004-12-07 Morphochem Ag Komb Chemie Compostos que inibem a atividade do fator xa
DE10300049A1 (de) * 2003-01-03 2004-07-15 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Faktor VIIa inhibieren
DE10330900B4 (de) * 2003-07-01 2006-09-14 Leibniz-Institut Für Polymerforschung Dresden E.V. Biomaterial mit einem modularen Beschichtungssystem zur Anwendung in Medizinprodukten mit direktem Blutkontakt
EP1574516A1 (en) * 2004-03-05 2005-09-14 Sanofi-Aventis Antithrombotic compound
TW200621794A (en) * 2004-10-06 2006-07-01 Akzo Nobel Nv Pulmonary administration of an antithrombotic compound
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) * 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
ES2362011T3 (es) * 2005-10-10 2011-06-27 N.V. Organon Inhibidores duales antitrombóticos anticoagulantes que comprenden una marca de biotina.
US20090111769A1 (en) * 2005-10-10 2009-04-30 De Kort Martin Antithrombotic Compound
EP2421878B1 (en) * 2008-10-03 2017-06-14 Glycan Biosciences LLC Anionic oligosaccharide conjugates
CN114423785A (zh) 2019-07-01 2022-04-29 通尼克斯制药有限公司 抗-cd154抗体及其用途
MX2023008055A (es) 2021-01-06 2023-08-22 Tonix Pharma Ltd Métodos para inducir tolerancia inmune con anticuerpos anti-cd154 modificados.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT84170B (pt) * 1986-01-24 1989-03-30 Sanofi Sa Processo para a preparacao de derivados n alfa-substituidos das n alfa-aril-sulfonilaminoacil d-amidinofenil-alaninamidas
DE4115468A1 (de) 1991-05-11 1992-11-12 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
DE4206858A1 (de) * 1992-03-05 1993-09-09 Behringwerke Ag Glycopeptid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel
EP0649854B1 (en) * 1993-09-01 2000-03-15 Akzo Nobel N.V. Bisconjugates comprising two saccharides and a spacer
IL120722A (en) * 1996-05-08 1999-07-14 Akzo Nobel Nv Polysulfated tetrasaccharide derivatives and pharmaceutical compositions containing them
CA2334863C (en) * 1998-06-17 2011-02-15 Akzo Nobel Nv Antithrombotic compounds

Also Published As

Publication number Publication date
PE20000700A1 (es) 2000-08-14
AR019674A1 (es) 2002-03-13
DE69939378D1 (de) 2008-10-02
HUP0102764A2 (hu) 2001-12-28
TWI221156B (en) 2004-09-21
KR100790910B1 (ko) 2008-01-03
ATE405580T1 (de) 2008-09-15
PL199433B1 (pl) 2008-09-30
CZ20004735A3 (cs) 2001-08-15
ZA200007075B (en) 2002-02-28
DK1087992T3 (da) 2008-11-24
ID26614A (id) 2001-01-25
IL139955A0 (en) 2002-02-10
HUP0102764A3 (en) 2003-11-28
AU756493B2 (en) 2003-01-16
KR20010052943A (ko) 2001-06-25
CA2334863C (en) 2011-02-15
CN1261450C (zh) 2006-06-28
EP1087992B1 (en) 2008-08-20
HK1034266A1 (en) 2001-10-19
SK19222000A3 (sk) 2001-07-10
CO5080750A1 (es) 2001-09-25
CA2334863A1 (en) 1999-12-23
CN1305494A (zh) 2001-07-25
BR9911300A (pt) 2001-04-03
NO326057B1 (no) 2008-09-08
JP2002518407A (ja) 2002-06-25
NO20006317D0 (no) 2000-12-12
PL345238A1 (en) 2001-12-03
NZ508623A (en) 2002-11-26
RU2225869C2 (ru) 2004-03-20
HU229088B1 (en) 2013-07-29
JP4369052B2 (ja) 2009-11-18
PT1087992E (pt) 2008-10-17
CZ299382B6 (cs) 2008-07-09
EP1087992A1 (en) 2001-04-04
NO20006317L (no) 2001-02-14
CY1108567T1 (el) 2014-04-09
ES2312210T3 (es) 2009-02-16
WO1999065934A1 (en) 1999-12-23
US6486129B1 (en) 2002-11-26
TR200003710T2 (tr) 2001-04-20
IL139955A (en) 2006-08-20
AU4512999A (en) 2000-01-05

Similar Documents

Publication Publication Date Title
US6486129B1 (en) Antithrombotic compounds
JP5632886B2 (ja) ビオチン残基を含む抗血栓性デュアルインヒビター
JP4820517B2 (ja) 抗血栓性化合物
MXPA00012554A (en) Antithrombotic compounds
MXPA02005278A (en) Antithrombotic compound

Legal Events

Date Code Title Description
PC4A Assignment and transfer of rights

Owner name: UNIVERSITEIT LEIDEN, LEIDEN, NL

Free format text: FORMER OWNER: UNIVERSITEIT LEIDEN, LEIDEN, NL; N.V. ORGANON, OSS, NL

Effective date: 20120326

Owner name: MSD OSS B.V., OSS, NL

Free format text: FORMER OWNER: UNIVERSITEIT LEIDEN, LEIDEN, NL; N.V. ORGANON, OSS, NL

Effective date: 20120326

PC4A Assignment and transfer of rights

Owner name: UNIVERSITEIT LEIDEN, LEIDEN, NL

Free format text: FORMER OWNER: UNIVERSITEIT LEIDEN, LEIDEN, NL; MSD OSS B.V., OSS, NL

Effective date: 20130729

Owner name: UNIVERSITEIT LEIDEN, LEIDEN, NL

Free format text: FORMER OWNER: UNIVERSITEIT LEIDEN, LEIDEN, NL; ORGANON BIO- -SCIENCES NEDERLAND B.V., AB OSS, NL

Effective date: 20130729

Owner name: ORGANON BIO- -SCIENCES NEDERLAND B.V., AB OSS, NL

Free format text: FORMER OWNER: UNIVERSITEIT LEIDEN, LEIDEN, NL; MSD OSS B.V., OSS, NL

Effective date: 20130729

Owner name: MERCK SHARP & DOHME B.V., BN HAARLEM, NL

Free format text: FORMER OWNER: UNIVERSITEIT LEIDEN, LEIDEN, NL; ORGANON BIO- -SCIENCES NEDERLAND B.V., AB OSS, NL

Effective date: 20130729

MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20160611